Rickard Jason's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed Nov 24, 2021
- Accession no.
- 0001209191-21-066782
- Filed
- Nov 24, 2021
- Trade date
- Nov 23, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $199.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rickard JasonCIK 0001808505 | Officer (SVP, Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 23, 2021 | Class A Common Stock | SSaleDisposed | −427 | $11.58 | −$4,944.66 | 361,431 | Direct | |
| Nov 23, 2021 | Class A Common Stock | SSaleDisposed | −16,766 | $11.58 | −$194,150.28 | 344,665 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.